Leanbio offers customized products and services for BioPharma industries in order to provide recombinant proteins produced in Mammalian cell lines, Plants, Yeast and Bacteria. Leanbio provides the development and manufacturing of New Biological entities and Biosimilars to support POC, non-clinical and clinical trials and industrial routine manufacturing. Leanbio has already participated in the development of above 50 NBE and 6 Biosimilar products providing a remarkable expertise in this field.
Enlace externo para LeanBioPro
Av. Dr. Marañón 8
Barcelona, Cataluña 08028, ES
LeanBioPro ha compartido esto
🚀💡 Expansión i Biocat, BioRegion of Catalonia destaquen les TOP20 rondes de finançament en startups de l'ecosistema català de salut 2024 👉 bit.ly/4fQkLYN 📊 Al rànquing, 5 entitats de la #PCBCommunity: 🔹 INBRAIN Neuroelectronics: 46,2 M€ 🧠💻 🔹 LeanBioPro: 5,8 M€ 💊⚙️ 🔹 Nanobots Therapeutics: 3,3 M€ 🤖🔬 🔹 Fecundis Lab: 3,1 M€ 🧪👶 🔹 Hemostatics: 2,5 M€ 🩸🩹
LeanBioPro ha compartido esto
🧐 Missed the launch of our FI Testimonials campaign? 🚀 We’re thrilled to share the experiences of our clients, starting with Albert Font Ingles CEO of LeanBioPro. Founded in 2014, LeanBioPro is a trailblazing startup delivering innovative solutions for biological product development, particularly in the biopharmaceutical sector. Discover how FI Group supported LeanBioPro in securing a #grant and the key achievements and benefits our collaboration has delivered. 🎥 Watch the video below to uncover their inspiring story! #FITestimonials #FIGroup #HelpingIdeasGrow #Clients
LeanBioPro ha compartido esto
Reflecting on yesterday’s inspiring roundtable discussion, “David vs. Goliath in the Pharma and Biotech Sector,” I can't help but feel grateful for the enriching experience. The evening was filled with insightful discussions, shared learnings, and a palpable energy among both the panelists and the audience. It was fantastic to see how comfortable everyone felt—both on stage and in the audience. The topics we covered, from paradigm shifts in the pharma and biotech business models to the emotional aspects of entrepreneurship and strategies for building high-performing teams, sparked thought-provoking conversations. Even more inspiring were the stories and experiences shared by attendees, bringing new perspectives and fueling a lively exchange of ideas. Thank you to IQS Barcelona and Klinea BioPharmaceutical Engineering, our outstanding moderator Marc Ramoneda, and my fellow panelists: Miquel Costa Ferrando (Aglaris Ltd Group), Joan Perelló Bestard (CSL Vifor), Guillem Laporta, CFA (Ysios Capital), and Jordi Martorell (Aortyx). Special thanks to Salvador Borrós for the introduction and Eduard Marti Mateo for the closing remarks, as well as to the incredible audience who made the event so interactive and meaningful. Let’s continue embracing change and driving innovation in this fast-evolving sector. Together, we can truly make a difference. #Leanbio #Biotech #BioPharma #Networking #CDMO
LeanBioPro ha compartido esto
📢 Cuando David desafía a Goliat en farma y biotec… ¡surgen grandes ideas! 📢 Junto a IQS Barcelona e IQS Alumni, en Klinea organizamos la mesa redonda "David contra Goliat en el sector farma y biotec". Tuvimos una conversación inspiradora sobre cómo las start-ups enfrentan a las grandes corporaciones, y debatimos el cambio de paradigma, el lado emocional de emprender y cómo construir equipos de alto impacto. Fue un honor contar con la participación de líderes como Miquel Costa Ferrando (Aglaris Ltd Group), Albert Font Ingles (LeanBioPro), Joan Perelló Bestard (CSL Vifor), Guillem Laporta, CFA (Ysios Capital) y Jordi Martorell (Aortyx). Y por supuesto, Marc Ramoneda, Partner y CEO de Appliant - Apps GMP Compliant 🌐 ¡Agradecemos a los participantes y a todos los asistentes por sumarse a esta gran experiencia! #evento #farma #biotech 🔹🔹🔹 📢 Quan David desafia Goliat en el sector farma i biotec… sorgeixen grans idees! 📢 Juntament amb IQS Barcelona i IQS Alumni, a Klinea BioPharmaceutical Engineering hem organitzat la taula rodona "David contra Goliat en el sector farma i biotec". Vam gaudir d’una conversa inspiradora sobre com les start-ups s’enfronten a les grans corporacions i vam debatre sobre el canvi de paradigma, el vessant emocional d’emprendre i com construir equips d’alt impacte. Va ser un honor comptar amb la participació de líders com Miquel Costa Ferrando (Aglaris Ltd Group), Albert Font Ingles (LeanBioPro), Joan Perelló Bestard (CSL Vifor), Guillem Laporta, CFA (Ysios Capital), Jordi Martorell (Aortyx) i, per descomptat, amb Marc Ramoneda, Partner i CEO d’Appliant - Apps GMP Compliant 🌐. Agraïm als participants i a tots els assistents per sumar-se a aquesta gran experiència! 🔹🔹🔹 📢 When David challenges Goliath in pharma and biotech... great ideas emerge! 📢 Together with IQS Barcelona and IQS Alumni, at Klinea BioPharmaceutical Engineering we organized the round table “David versus Goliath in pharma and biotech”. We had an inspiring conversation about how start-ups face big corporations. We discussed the paradigm shift, the emotional side of entrepreneurship, and how to build high-impact teams. It was an honor to have leaders such as Miquel Costa Ferrando (Aglaris Ltd Group), Albert Font Ingles (LeanBioPro), Joan Perelló Bestard (CSL Vifor), Guillem Laporta, CFA (Ysios Capital), and Jordi Martorell (Aortyx) participate. And, of course, Marc Ramoneda, Partner and CEO of Appliant -Apps GMP Compliant. We thank the participants and all the attendees for joining this great experience!
Meet our Head of BD at BioEurope fall 2024!!!
and... yes, again on the road! This time in Stockholm at BIOEUROPE, thrilled to be representing Leanbio , its capabilities and is tremendous dynamic and skilled team. Hoping to generate new valuable leads and partnerships! Go ahead 🚀🚀
We are at The World Vaccine Congress, come to visit Albert Font Ingles and Jordi Sarrà Herrera to explore the options we have to partner. Today we have accomplished another milestone: Leanbio's first booth ever!!! It may seem a little step for a company but we want to recognize the great work (also behind the scenes) our team is doing on the field during the last year generating awareness of the great value Leanbio is willing to add to our partners. More to come soon!
Meet our Head of BD at the Orphan Drug Conference. We will be delighted to add to your project with our solutions
On the road again! This time at home, Barcelona. Scouting options among rare diseases at the World Orphan Drug Congress Europe 💪🏻
LeanBioPro ha compartido esto
🚀 FI Testimonials Campaign Launch! 🚀 We are thrilled to kick off our FI Testimonials campaign, where we’ll dive into how we help our clients' ideas grow and share what our #customers think of us 💭 First up, we have an exclusive interview with Albert Font Ingles CEO of LeanBioPro! Founded in 2014, LeanBioPro is a pioneering startup providing innovative solutions for biological product development, particularly in the biopharmaceutical sector. Discover how FI Group helped LeanBioPro secure a #grant, unlocking key benefits and achievements. 👇 Check out the video to see how FI Group has been driving LeanBio’s innovation journey! #FITestimonials #FIGroup #HelpingIdeasGrow #Clients